Pathophysiology and classification of emphysema

Chest Surgery Clinics of North America

Volumn 13, Issue 4, 2003, Pages 589-613

  Keller, Cesar A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRFLOW; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; HUMAN; LUNG EMPHYSEMA; PATHOPHYSIOLOGY; POLICY; PRIORITY JOURNAL; REVIEW; SMOKING; TOBACCO INDUSTRY;

EID: 0344394427     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(03)00092-9     Document Type: Review

References (77)

1. Pawels RA, Buist AS, Calverley PM, Jenkins CR, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI\WHO Global Initiative of Obstructive Lung Disease (GOLD) workshop summary 200. Am J Respir Crit Care Med 2001;163:1267-76.
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121.
3. Snider GL, Kleinerman J, Thurlbeck WM, et al. The definition of emphysema. Report of a National Heart, Lung and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 1985;132:182-5.
4. Flaherty KR, Martinez FJ. Lung volume reduction surgery for emphysema. Clin Chest Med 2000;21:819-48.
5. Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin Chest Med 2000;21:67-85.
6. Auerbach O, Hammond EC, Garfinkel L, et al. Relationship of smoking and age to emphysema: whole-lung section study. N Engl J Med 1972;286:853-7.
7. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
8. Gurney JW. Pathophysiology of obstructive airways disease. Radiol Clin N Am 1998;36(1): 15-27.
9. 210 in pulmonary tissues of cigarette smokers. N Engl J Med 1965;273:1343-51.
10. Remy-Jardin M, Remy J, Gosselin B, et al. Lung parenchymal changes secondary to cigarette smoking: pathologic CT correlations. Radiology 1993;186:262-6.
11. Friedman PJ, Liebow AA, Sokolof J. Clinical aspects of primary pulmonary histiocytosis. Medicine 1901;60:385-96.
12. Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes. An epidemiologic inquiry. J Natl Cancer Inst 1984;72:1271-5.
13. Erikkson S. Alpha-1 antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Chest 1989;95:181-6.
14. Erikkson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1 antitrypsin deficiency. N Engl J Med 1986;314:736-41.
15. Macdonald JL, Johnosn CE. Pathophysiology and treatment of alpha sub 1 antitrypsin deficiency. Am J Health Syst Pharm 1995;52:481-9.
16. Coakley RJ, Taggart C, O'Neill S, et al. Alpha-1 antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 2001;321:33-41.
17. Sifers RN, Finegold MJ, Woo SL. Molecular biology and genetics of alpha sub 1 antitrypsin deficiency. Sem Liver Dis 1992;12:301-10.
18. Rogers J, Kalsheheker N, Wallis S, et al. The isolation of a clone for alpha 1 antitrypsin mRNA from liver and lewukocytes. Biochem Biophys Res Commun 1983;116:375-82.
19. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988;84:13-31.
20. Janus ED, Phillips NT, Carrell RW. Smoking, lung function and alpha-1 antitrypsin deficiency. Lancet 1985;19:152-4.
21. Turino GM, Barker AF, Brantly ML, et al. Clinical features of individuals with Pi SZ phenotype of alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 1996;154:1718-25.
22. Seersholm N, Wilcke JT, Kok-Jensen A, et al. Risk of hospital admission for obstructive pulmonary disease in alpha-1-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 2000;161:81-4.
23. Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-8.
24. Buist AS. The US lung health study. Respirology 1997;2:303-7.
25. U.S. Surgeon General. The health consequences of smoking. Chronic obstructive lung disease. Washington DC: US Department of Health and Human Services; 1984.
26. Burrows B, Knudson RJ, Lebowitz MD. The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis 1977;115:751-60.
27. Lebowitz MD. Respiratory symptoms and disease related to alcohol consumption. Am Rev Respir Dis 1981;123:16-9.
28. Lange P, Groth S, Nyboe J, et al. Pulmonary function is influenced by heavy alcohol consumption. Am Rev Respir Dise 1988;137:1119-23.
29. Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic and induced sputum features of chronic obstructive pulmonary disease in non-smokers: a descriptive study. Am J Respir Crit Care Med 2002;166:1078-83.
30. Dahmi R, Gilks B, Xie C, et al. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha-1 antitrypsin. Am J Respir Cell Mol Biol 2000;22:244-52.
31. Erikkson S. Pulmonary emphysema and alpha-1 antitrypsin deficiency. Acta Med Scand 1964;175:197-205.
32. Janoff A, Sloan B, Weinbaum G, et al. Experimental emphysema induced with purified human neutrophil elastase. Am Rev Respir Dis 1977;115:461-78.
33. Ludwig P, Schwartz B, Hoidal J, et al. Cigarette smoking causes accumulation of polymorphonuclear leukocytes in the alveolar septum. Am Rev Respir Dis 1985;131:828-30.
34. Eidelman D, Saetta M, Ghezzo H, et al. Cellularity of the alveolar cell walls in smokers and its relationship to alveolar destruction. Am Resv Respir Dis 1990;141:1547-52.
35. Morrison HM, Kramps JA, Burnett D, et al. Lung lavage fluid from patients with alpha-1 proteinase inhibitor deficiency or chronic bronchitis: anti-elastase function and cell profile. Clin Sci 1987;72:373-81.
36. Ogushi F, Hubbard RC, Vogelmeier C, et al. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha-1 antitrypsin for neutrophil elastase. J Clin Invest 1991;87:1060-5.
37. Hubbard RC, Ogushi F, Fells GA, et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha-1 antitrypsin, rendering ineffective as inhibitor of neutrophil elastase. J Clin Invest 1987;80:1289-95.
38. Churg A, Rong DW, Hsin T, et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor release. Am J Respir Crit Care Med 2003;167:1083-9.
39. Tetley TD. Macrophages and the pathogenesis of COPD. Chest 2002;121:156S-9S.
40. Hautamaki R, Kobayashi D, Senior R, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-4.
41. Finkelstein R, Fraser R, Ghezzo H, et al. Alveolar inflammation and its relation with emphysema in smokers. Am J Respir Crit Care Med 1995;152:1666-72.
42. Senior R, Connolly N, Cury J, et al. Elastin degradation by human alveolar macrophages. Am Rev Respir Dis 1989;139:1251-6.
43. Shapiro SD. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Am J Respir Crit Care Med 1994;150:S160-4.
44. Ohnishi K, Takagi M, Kurokawa Y, et al. Metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998;78:1077-86.
45. Churg A, Dai J, Tai H, et al. TNF-α is crucial to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-54.
46. Snider GL. Understanding inflammation in chronic obstructive pulmonary disease: the process begins. Am J Respir Crit Care Med 2003;167:1045-6.
47. O'Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammatory cells in the airway surface epithelium of bronchitic smokers with and without airflow obstruction. Am J Respir Crit Care Med 1997;155:852-7.
48. Jamal K, Cooney TP, Fleetham JA, Thurlbeck WM. Chronic bronchitis. Correlation of morphologic findings to sputum production and flow rates. Am Rev Respir Dis 1984;129:719-29.
49. Hogg JC, Maclem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-60.
50. Hogg JC, Wright JL, Wiggs BR, et al. Lung structure and function in cigarette smokers. Thorax 1994;49:473-8.
51. Saetta M, Ghezzo H, Kim WD, et al. Loss of alveolar attachment in smokers, a morphometric correlate of lung function impairment. Am Rev Respir Dis 1985;132:894-900.
52. Mead J, Turner JM, Macklem PT, et al. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967;22:95-108.
53. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
54. Gould GA, Redpath AT, Ryan M, et al. Lung CT density correlates with measurements of airflow limitation and diffusion capacity. Eur Respir J 1991;4:141-6.
55. Pugatch RD. The radiology of emphysema. Clin Chest Med 1983;4:433-42.
56. Keller CA, Ruppel G, Hibbett A, et al. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med 1997;156:60-7.
57. Keller CA, Ohar J, Ruppel G, et al. Right ventricular function in patients with severe COPD evaluated for lung transplantation. Chest 1995;107:1510-6.
58. Baurle O, Chrusch CA, Younes M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998;157:57-68.
59. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.
60. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;166:314-22.
61. Gurney JW. Pathophysiology of obstructive lung disease. Radiol Clin N Am 1998;36:15-27.
62. Wright JL. Emphysema: concepts under change-a pathologist's perspective. Mod Pathol 1995;8:873-80.
63. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121.
64. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Pulmonary rehabilitation: joint ACCP/AACVPR evidence based guidelines. Chest 1997;112:1363-96.
65. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Int Med 1980;93:391-8.
66. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996;112:1319-30.
67. Bingisser R, Zollinger A, Hauser M, et al. Bilateral volume reduction surgery for diffuse pulmonary emphysema by video-assisted thoracoscopy. J Thorac Cardiovasc Surg 1996;112:875-82.
68. Naunheim KS, Keller CA, Krucylak PE, et al. Unilateral video-assisted thoracic surgical lung reduction. Ann Thorac Surg 1996;61:1092-8.
69. The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial (NETT): a prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 1999;118:518-28.
70. Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology 1999;211:851-8.
71. Bergin M, Mulle NL, Nichols DM, et al. The diagnosis of emphysema: a computed tomographic-pathologic correlation. Am Rev Respir Dis 1986;133:541-6.
72. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume resduction surgery. N Engl J Med 2001;345:1075-83.
73. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73.
74. Drazen JM, Epstein AM. Guidance concerning surgery for emphysema. N Engl J Med 2003;348:2134-5.
75. National Emphysema Treatment Trial Research Group. Cost effectiveness of lung volume reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092-102.
76. The United Network for Organ Sharing. Available at: http://www.unos.org. Accessed in 2003.
77. Joint Statement of the ASTP/ATS/ERS/ISHLT. International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998;158:335-9.